135 related articles for article (PubMed ID: 7755350)
1. Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy.
Rinne JO; Burn DJ; Mathias CJ; Quinn NP; Marsden CD; Brooks DJ
Ann Neurol; 1995 May; 37(5):568-73. PubMed ID: 7755350
[TBL] [Abstract][Full Text] [Related]
2. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.
Brooks DJ; Salmon EP; Mathias CJ; Quinn N; Leenders KL; Bannister R; Marsden CD; Frackowiak RS
Brain; 1990 Oct; 113 ( Pt 5)():1539-52. PubMed ID: 2123119
[TBL] [Abstract][Full Text] [Related]
3. Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography.
Gilman S; Frey KA; Koeppe RA; Junck L; Little R; Vander Borght TM; Lohman M; Martorello S; Lee LC; Jewett DM; Kilbourn MR
Ann Neurol; 1996 Dec; 40(6):885-92. PubMed ID: 9007093
[TBL] [Abstract][Full Text] [Related]
4. Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, A [11C]diprenorphine PET study.
Burn DJ; Rinne JO; Quinn NP; Lees AJ; Marsden CD; Brooks DJ
Brain; 1995 Aug; 118 ( Pt 4)():951-8. PubMed ID: 7655890
[TBL] [Abstract][Full Text] [Related]
5. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Brooks DJ; Ibanez V; Sawle GV; Quinn N; Lees AJ; Mathias CJ; Bannister R; Marsden CD; Frackowiak RS
Ann Neurol; 1990 Oct; 28(4):547-55. PubMed ID: 2132742
[TBL] [Abstract][Full Text] [Related]
6. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease.
Antonini A; Leenders KL; Vontobel P; Maguire RP; Missimer J; Psylla M; Günther I
Brain; 1997 Dec; 120 ( Pt 12)():2187-95. PubMed ID: 9448574
[TBL] [Abstract][Full Text] [Related]
7. Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study.
Thobois S; Ribeiro MJ; Lohmann E; Dürr A; Pollak P; Rascol O; Guillouet S; Chapoy E; Costes N; Agid Y; Remy P; Brice A; Broussolle E;
Arch Neurol; 2003 May; 60(5):713-8. PubMed ID: 12756135
[TBL] [Abstract][Full Text] [Related]
8. Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy.
Gilman S; Koeppe RA; Junck L; Kluin KJ; Lohman M; St Laurent RT
Ann Neurol; 1994 Aug; 36(2):166-75. PubMed ID: 8053652
[TBL] [Abstract][Full Text] [Related]
9. Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data.
Burn DJ; Sawle GV; Brooks DJ
J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):278-84. PubMed ID: 8158173
[TBL] [Abstract][Full Text] [Related]
10. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease.
Leenders KL; Salmon EP; Tyrrell P; Perani D; Brooks DJ; Sager H; Jones T; Marsden CD; Frackowiak RS
Arch Neurol; 1990 Dec; 47(12):1290-8. PubMed ID: 2123623
[TBL] [Abstract][Full Text] [Related]
11. Separating Parkinson's disease from normality. Discriminant function analysis of fluorodopa F 18 positron emission tomography data.
Sawle GV; Playford ED; Burn DJ; Cunningham VJ; Brooks DJ
Arch Neurol; 1994 Mar; 51(3):237-43. PubMed ID: 8129633
[TBL] [Abstract][Full Text] [Related]
12. Asymmetrical pre-synaptic and post-synpatic changes in the striatal dopamine projection in dopa naïve parkinsonism. Diagnostic implications of the D2 receptor status.
Sawle GV; Playford ED; Brooks DJ; Quinn N; Frackowiak RS
Brain; 1993 Aug; 116 ( Pt 4)():853-67. PubMed ID: 8353712
[TBL] [Abstract][Full Text] [Related]
13. Preclinical impairment of the striatal dopamine transporter system in sporadic olivopontocerebellar atrophy: studied with [(123)I]beta-CIT and SPECT.
Kim GM; Kim SE; Lee WY
Eur Neurol; 2000; 43(1):23-9. PubMed ID: 10601804
[TBL] [Abstract][Full Text] [Related]
14. 11C-diprenorphine binding in Huntington's disease: a comparison of region of interest analysis with statistical parametric mapping.
Weeks RA; Cunningham VJ; Piccini P; Waters S; Harding AE; Brooks DJ
J Cereb Blood Flow Metab; 1997 Sep; 17(9):943-9. PubMed ID: 9307607
[TBL] [Abstract][Full Text] [Related]
15. Benzodiazepine receptor binding in cerebellar degenerations studied with positron emission tomography.
Gilman S; Koeppe RA; Junck L; Kluin KJ; Lohman M; St Laurent RT
Ann Neurol; 1995 Aug; 38(2):176-85. PubMed ID: 7654065
[TBL] [Abstract][Full Text] [Related]
16. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.
Turjanski N; Lees AJ; Brooks DJ
Neurology; 1999 Mar; 52(5):932-7. PubMed ID: 10102408
[TBL] [Abstract][Full Text] [Related]
17. A comparison of 11C-labeled L-DOPA and L-fluorodopa as positron emission tomography tracers for the presynaptic dopaminergic system.
Torstenson R; Tedroff J; Hartvig P; Fasth KJ; Långström B
J Cereb Blood Flow Metab; 1999 Oct; 19(10):1142-9. PubMed ID: 10532639
[TBL] [Abstract][Full Text] [Related]
18. Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction.
Ruottinen HM; Rinne JO; Oikonen VJ; Bergman JR; Haaparanta MT; Solin OH; Ruotsalainen UH; Rinne UK
Synapse; 1997 Dec; 27(4):336-46. PubMed ID: 9372556
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography (PET) in Machado-Joseph disease.
Taniwaki T; Sakai T; Kobayashi T; Kuwabara Y; Otsuka M; Ichiya Y; Masuda K; Goto I
J Neurol Sci; 1997 Jan; 145(1):63-7. PubMed ID: 9073030
[TBL] [Abstract][Full Text] [Related]
20. Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study.
Perani D; Bressi S; Testa D; Grassi F; Cortelli P; Gentrini S; Savoiardo M; Caraceni T; Fazio F
Arch Neurol; 1995 Feb; 52(2):179-85. PubMed ID: 7848128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
